See all treatments in the PatientsLikeMe system shared by patients just like you.
See also: Vitamin B12 (cyanocobalamin), Vitamin B12 (hydroxycobalamin)
What is Vitamin B12 Injection? Vitamin B12 injections are used to treat pernicious anemia. This is due to the fact that they are unable to absorb sufficient vitamin B12 from their dietary food sources. It is thought that injections can serve therapeutic purposes as well as deficiencies.
98 patients in the community are taking or have taken Vitamin B12 Injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Fatigue | 29 | 29% |
| General health | 22 | 22% |
| Other | 16 | 16% |
| Slow my MS progress | 7 | 7% |
| Support another treatment | 3 | 3% |
| disease-related symptoms | 3 | 3% |
| Don't know | 2 | 2% |
| Slow my ALS progress | 2 | 2% |
| Anemia | 1 | 1% |
| HIV related neurological symptoms | 1 | 1% |
Based on the patients currently taking Vitamin B12 Injection.
Top 10 (Show all)
All (Show Top 10)
| 0 month | 0 mcg none | 0 mg none | 0 other none | 0 mg week | 0 week | 0.014286 mg week | 0.03333 g month | 0.03333 mcg month | 0.03333 mg month | 0.03333 mL month | 0.03333 month | 0.14286 mg week | 0.14286 other week | 0.14286 week | 0.16665 mg month | 0.39996 mg month | 0.42858 mg week | 0.49995 mg month | 0.49995 month | 1.4286 mcg none | 3.333 mg month | 7.143 mg week | 7.143 mL week | 14.286 mg week | 33.33 mcg month | 33.33 mg month | 71.43 mg week | 71.43 mcg week | 71.43 mg month | 100 mg day | 142.86 mcg week | 142.86 mg week | 142.86 mcg month | 200 mg day | 1000 mg day | 1000 mL day | 1428.6 mg week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4
|
1
|
2
|
1
|
8
|
2
|
1
|
1
|
1
|
5
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
5
|
1
|
1
|
3
|
1
|
1
|
||
How long current patients have been taking Vitamin B12 Injection or how long patients were taking Vitamin B12 Injection before stopping.
Results from 5 patient evaluations. See the overall results and all individual evaluations.
| Major | 33% | 1 |
|---|---|---|
| Moderate | 33% | 1 |
| Slight | 33% | 1 |
Fatigue
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 20% | 1 |
| None | 80% | 4 |
Top reported side-effects include: JITTERY
Summary results are based on 5 individual responses. For more information, see overall results for Adherence, Burden and Cost.